Skip to main content
Premium Trial:

Request an Annual Quote

Bruker Rolls Out New Mass Spectrometers

NEW YORK, March 5 - Bruker Daltonics introduced three new MALDI/TOF mass spectrometers, a new ion trap mass spectrometer, and improvements to its Biotof mass spectrometer on Monday at the Pittsburgh Conference 2001 in New Orleans, La., the company said.

The company's new MALDI/TOF mass spectrometers include the ultra-high throughput autoflex, and the high-throughput Reflex IV and Biflex IV, which are designed for SNP and protein analysis. Reflex IV and Biflex IV have a Windows NT/2000 user interface. Additionally, the Reflex offers fully automated MS/MS structure-specific fragmentation, according to the company.

Bruker did not disclose the list prices of these new systems. 

Bruker also introduced the analytical esquire2000 electrospray ionization ion trap LS/MS/MS mass spectrometer, and an updated version of its Biotof ESI-TOF mass spectrometer.

The esquire2000, with a mass range of up to 2200 m/z, has a U.S. list price of $130,000 and works together with the Agilent ChemStation. The Biota II has better resolution than its previous version, and is designed for studying protein mixtures, as well as protein-protein, protein-DNA, and protein-drug interactions, Bruker said.

Bruker's major customers include Geneva Proteomics, which has purchased 51 mass spectrometers from the company in September, and Large Scale Biology. 

Currently, the company is expanding its R&D and manufacturing facilities and building European, Asian, and Australian distribution channels.

The Scan

Boosters Chasing Variants

The New York Times reports that an FDA advisory panel is to weigh updated booster vaccines for COVID-19.

Not Yet

The World Health Organization says monkeypox is not yet a global emergency, the Washington Post reports.

More Proposed for Federal Research

Science reports that US House of Representatives panels are seeking to increase federal research funding.

PLOS Papers on Breast Cancer Metastasis, Left-Sided Cardiac Defects, SARS-CoV-2 Monitoring

In PLOS this week: link between breast cancer metastasis and CLIC4, sequencing analysis of left-sided cardiac defects, and more.